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Abstract
Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder of the central nervous system.
Although the causes of PD pathogenesis remain incomplete, some evidences has suggested that oxidative stress is
an important mediator in its pathogenesis. The aim of this study was to evaluate the protective effects of seaweeds
with high antioxidant activity on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in the human neuroblastoma
cell line SH-SY5Y, as well as the associated intracellular signaling pathways.
Methods: Cell viability studies were assessed by 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium (MTT) bromide
assay and the intracellular signaling pathways analyzed were: hydrogen peroxide (H2O2) production, changes in the
mitochondrial membrane potential and Caspase-3 activity.
Results: Exposure of SH-SY5Y cells to 6-OHDA (10–1000 μM) reduced cell’s viability in a concentration and time-
dependent manner. The data suggest that the cell death induced by 6-OHDA was mediated by an increase of H2O2
production, the depolarization of mitochondrial membrane potential and the increase of Caspase-3 activity. Extracts
from S. polyshides, P. pavonica, S. muticum, C. tomentosum and U. compressa revealed to efficiently protect cell’s viability
in the presence of 6-OHDA (100 μM; 24 h). These effects appear to be associated with the reduction of H2O2 cell’s
production, the protection of mitochondrial membrane’s potential and the reduction of Caspase-3 activity.
Conclusions: These results suggest that seaweeds can be a promising source of new compounds with
neuroprotective potential.
Keywords: Parkinson’s disease, Substantia nigra, Mitochondrial membrane potential, Caspase – 3 activity,
Oxidative stress, Apoptosis, Marine natural bioactive compounds
Background
Currently with the increasing of life expectancy and the
demographic changes in population, neurodegenerative
diseases, such as Alzheimer’s and Parkinson’s disease
(PD) are becoming frighteningly common [1, 2].
PD is a progressive neurodegenerative disorder of un-
known etiology that is characterized by a progressive
loss of dopaminergic neurons in substantia nigra pars
compacta (SNpc) that underlie characteristic motor
symptoms such as rigidity, tremor, slowness of move-
ment, and postural abnormalities [3]. Neuropathology of
PD includes insufficient striatal dopamine formation and
activity, arising from the death of dopaminergic neurons
in SNpc region of the brain. Although the causes of PD
pathogenesis remains incomplete, considerable evidences
from human and animal studies have suggested that
many pathological mechanisms such as oxidative stress,
mitochondrial and lysosomal dysfunctions, neuroinflam-
matory processes, and the formation of pathologic inclu-
sions, contribute to neuronal death [4, 5]. In fact, the
nigral dopaminergic neurons are rich in reactive oxygen
species (ROS) due to the auto-oxidization of dopamine
at normal pH producing toxic dopamine-quinone spe-
cies, superoxide radicals (O2
•−), hydrogen peroxide
(H2O2), and hydroxyl radicals (·
•OH). This is supported
by increased levels of oxidative products of lipids,
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proteins, and DNA verified in the substantia nigra of PD
patients [6]. The pharmacologic treatment of PD can be
divided into symptomatic and neuroprotective therapies.
The aim of symptomatic strategy is to counteract the de-
ficiency of dopamine in the basal ganglia or to block
muscarinic receptors. By other side, the neuroprotective
therapy aims to slow, block, or reverse the disease pro-
gression. However, such therapies are defined as those
that slow the underlying loss of dopaminergic neurons.
In fact, at this time, there are no completely proven neu-
roprotective or disease-modifying therapies [5].
The neurotoxin 6-Hydroxydopamine (6-OHDA) is
widely used to mimic experimental models of PD since
it can selectively damage dopaminergic neurons in vivo
and in vitro. 6-OHDA has a similar structure to dopa-
mine and shows high affinity for the dopamine trans-
porter, therefore it selectively destroys dopaminergic/
catecholaminergic neurons [7, 8]. Once inside the
neuron, 6-OHDA accumulates and undergoes non-
enzymatic auto-oxidation, promoting reactive oxygen
species formation. Furthermore, 6-OHDA may provoke
the inhibition of mitochondrial complexes I and IV,
causing the adenosine triphosphate (ATP) depletion.
These evidences suggest the hypothesis that oxidative
stress and mitochondrial dysfunction are responsible for
the cell death induced by 6-OHDA [9, 10]. In addition,
human neuroblastoma SH-SY5Y is a dopaminergic neur-
onal cell line which has been used as an in vitro model
for the study of PD and to determine the effect of pro-
tective and therapeutic agents. These cells have become
a popular research cell model for PD due to the high
similarity with dopaminergic neurons [11–14]. The in-
creasing evidences that oxidative stress is critically in-
volved in the pathogenesis of PD suggest that
pharmacological targeting of the antioxidant machinery
may have therapeutic value [15]. In addition, several ex-
periments revealed that therapies including the intake of
synthetic and natural antioxidants have shown a protect-
ive effect on the degeneration of dopaminergic neurons
[6, 16–19]. Moreover, different studies indicate that the
intake of dietary food with high antioxidants content can
lower the associated risk of PD [20–24].
The marine environment is known as a rich source of
chemical structures with numerous beneficial health ef-
fects. It is widely accepted that marine natural products
provide unusual and unique chemical structures upon
which molecular modeling and chemical synthesis of
new drugs can be based with greater efficacy and specifi-
city for the treatment of human diseases [25–27].
Among marine organisms, seaweeds have been target of
numerous studies that show their potential as a rich
source of structurally diverse biologically active com-
pounds with great pharmaceutical and biomedical po-
tential [28]. Recently, several scientific studies have
provided an insight into biological activities and neuro-
protective effects of marine algae including antioxidant,
anti-neuroinflammatory, cholinesterase inhibitory activ-
ity and the inhibition of neuronal death suggesting that
marine algae have great potential to be used for neuro-
protection as part of pharmaceuticals, nutraceuticals and
functional foods [28–30]. In line with this, the main
aim of the present study was to investigate the protect-
ive effects of seaweeds extracts on 6-hydroxydopamine
(6-OHDA)-induced neurotoxicity in the human neuro-
blastoma cell line SH-SY5Y and the intracellular signal-
ing pathways involved in such effects.
Methods
Collection and identification of algae extracts
Seaweeds were collect freshly, between April and July of
2013, in Papôa (39°22′09.5″N 9°22′40.4 W), Quebrado
(39°22′04.6″N 9°22′26.1 W) and Gamboa (39°21′54.3″
N 9°22′22.7″) beaches, Peniche (Portugal) and immedi-
ately transported to laboratory. The seaweeds were then
washed with seawater to remove epiphytes, detritus and
encrusting material. Algae were identified as Padina
pavonica, Sargassum muticum, Saccorhiza polyschides
(Heterokontophyta division); Codium tomentosum, and
Ulva compressa (Chlorophyta division). Identification
was performed by Dr. Susete Pinteus, supported by
Marine Algae: Biodiversity, Taxonomy, Environmental
Assessment, and Biotechnology guide [31]. Finally algae
were kept at − 80 °C (Thermo Scientific, Electron
Corporation, Waltham, Massachusetts, USA) until
extraction process.
Preparation of seaweed extracts
Freeze dried seaweeds were sequentially extracted in a
1:40 biomass:solvent ratio with methanol (> 99%,
VWR, 20,903.368, Fontenay-sous-Bois, France) and
dichloromethane (99%, Fischer Scientifc, D/1852/21/,
Loughborough, United Kingdom) at constant stirring
for 12 h. Liquid-liquid extraction was also performed for
the methanolic fraction, using n-Hexane (99%, Fischer
Scientifc, D/1852/21/, Loughborough, United Kingdom).
The solvents were evaporated in a rotary evaporator
(Laborota 4000, Heidolph, Schwabach, Germany) at 40 °C
and the biomass obtained was then solubilized in dimethyl
sulfoxide (DMSO) (Sigma Aldrich, 274,380, Saint louis,
USA) and stored at − 20 °C until further use.
Cell culture
The experiments were performed on human neuroblast-
oma (SH-SY5Y cells), from DMSZ bank - German col-
lection of microorganisms and cell cultures (ACC 209)
and maintained with Dulbecco’s Modified Eagle’s
Medium (DMEM) (Sigma – Aldrich, D8900, Steinheim
am Albuch, Germany) supplemented with 20% (v/v) of
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fetal bovine serum (FBS) (Hyclone, SV30160.0,
Northumherlan, UK) and 1% of antibiotic/antimycotic
commercial solution (Hyclone, SV30079.01, Utah, USA).
For subcultures, SH-SY5Y cells were dissociated with
tripsin-EDTA (Hyclone, Thermoscientific, SV30031.01,
Waltham Massachusetts, USA), split into a 1:3 ratio and
subcultured into Petri dishes with 25 cm2 growth area.
Medium was replaced every 2 days until the cells
reached the total confluence (4–5 days of initial seeding).
Cells were maintained in the following controlled condi-
tions: 95% of humidified atmosphere, 5% of CO2 and
constant temperature of 37 °C.
Evaluation of neurotoxicity effects induced by 6-OHDA on
SH-SY5Y cells viability
The neurotoxicity induced by 6-OHDA (Sigma –
Aldrich, H4381 Steinheim am Albuch Germany) on SH-
SY5Y cells was evaluated in 96 well plates after the cells
reached total confluence. The cells were then incubated
with different concentrations of 6-OHDA (10, 30, 100,
300 and 1000 μM) during 24 h. The time-course effects
of 6-OHDA (100, 300 and 1000 μM) were also studied
after 12, 24 and 48 h of incubation. The solutions were
previous prepared in culture medium without FBS and
sterile filtered (0.2 μm) (Whatman, Maidstone, UK). The
effects were assessed by a colorimetric assay (570 nm)
based on the conversion of tetrazolium salts (MTT)
(Amresco, 0793-1G, Solon, USA) to blue formazan prod-
ucts by active mitochondria [32, 33]. Results were
expressed in percentage of control and as IC50 (concen-
tration causing 50% of cell viability reduction) where
applicable.
Cytotoxicity and protective effects of seaweeds extracts
on neurotoxicity induced by 6-OHDA
A previous work from our work group screened twenty
seven seaweeds for their antioxidant potential, revealing
12 extracts with high antioxidant activity [34]. Within
these, only 6 fractions didn’t exhibit toxicity on SH-
SY5Y cells (data not shown) being selected for the neu-
roprotective assays, namely: methanolic extracts –
Sargassum muticum, Sacchorhiza polyshides, Padina
pavonica; dichloromethane extracts – Sargassum
muticum, Codium tomentosum and Ulva compressa. The
neuroprotective effect of seaweeds extracts on SH-SY5Y
cells in the presence of 6-OHDA was tested after cells
reached total confluence in 96 well plates. Cells were in-
cubated with 6-OHDA (100 μM) and seaweeds extracts
(1 mg/mL) during 24 h.
MTT method
The solutions were previously prepared in culture
medium without FBS and sterile filtered (0.2 μm). The
effects were estimated by colorimetric assay (570 nm)
based on the conversion of tetrazolium salts (MTT) to a
blue formazan product by active mitochondria [32, 33].
Results were expressed in percentage of control.
Calcein –AM method
This method is based on the fluorophore calcein-AM
(Invitrogen, C31100MP, Waltham, Massachusetts, USA).
The calcein, in its natural form, exhibits fluorescence;
however once esterified (calcein-AM) loses this feature
and gain the ability to penetrate cell’s membranes.
Within this, the esterase existing in the cytoplasm break
the esters links, restoring calcein natural form. For ester-
ases to have a normal activity, cells must be viable,
therefore, the greater is the fluorescence intensity greater
is the number viable cells [35]. The procedure was
adapted from Pedrosa and Soares-da-Silva (2002) [36].
Cells cultured in 96 well plates were incubated with 6-
OHDA (100 μM) and seaweeds extracts that exhibited
protective activities (1 mg/mL) during 24 h. The solu-
tions were previously prepared in culture medium with-
out FBS and sterile filtered (0.2 μm). Briefly, cells were
washed twice with 200 μl of Hank’s buffer and loaded
with 100 μl of calcein (2 μM). The 96 well plates were
incubated at room temperature protected from light for
30 min and the fluorescence intensity of eight independ-
ent experiments were measured by a microplate reader
(Biotec, Synergy H1 Hybrid Reader) at wavelengths of
490 nm (excitation) and 520 nm (emission) scanning all
of each well surface. The results were expressed in per-
centage of control of the fluorescence scan read in eight
independent wells. After the reader the cells were
washed again with 200 μl Hank’s buffer and finally was
added 100 μl of Hank’s buffer to each situation. The
effects were observed in a fluorescence inverted
microscope (ZEISS Axio, VERT. A1, equipped with a
AxioCam MRC-ZEISS camera, München, Germany).
The images presented are representative of one well
center-point of each situation tested.
Quantification of hydrogen peroxide (H2O2) production
Quantification of H2O2 was performed using the
“Amplex ™ Red hydrogen peroxide Assay” Kit (Life
Tecnologies, A22188, Camarillo, USA). The amplex red
is a fluorophore that evidence a low basal fluorescence
which reacts in with H2O2 in a 1:1 ratio. This reaction is
initiated in the presence of horseradish peroxidase and
successive reactions occur leading to the appearance of
highly fluorescent product, designated resofurin [37].
H2O2 production was quantified in SH-SY5Y cells after
12 h of treatment with 6-OHDA (100 μM) in the ab-
sence or presence of seaweeds extracts (1 mg/mL). The
variation of H2O2 production was accompanied in real-
time along 60 min at room temperature. The fluores-
cence intensity was measured at wavelengths of 590 nm
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(excitation) and 530 nm (emission). The levels of H2O2
were calculated by the slope of the linear phase of fluor-
escence curve and the results were expressed in percent-
age of control.
Mitochondrial membrane potential (MMP)
MMP was determined using the fluorescent probe, JC-1
(Molecular Probes, T3168, Eugene, Oregon, USA). SH-
SY5Y cells were treated with 6-OHDA (100 μM), 3 and
6 h, in the absence or presence of seaweeds extracts
(1 mg/mL). After this period, the culture medium was re-
moved and the cells were washed with Hank’s buffer and
incubated 15 min at 37 °C with JC-1 (3 μM). JC-1 probe
was then removed and cells washed with Hank’s buffer.
The formation of JC-1 aggregates (490 nm of excitation
and 590 nm of emission) and the monomeric form of JC-1
(490 nm of excitation and 530 nm of emission) was
accompanied simultaneously in the plate reader during
30 min. Results were expressed as the ratio of the mono-
mers/aggregates of JC-1 in percentage of control.
Caspase-3 activity
Caspase-3 activity was assessed using “Caspase Assay
kit” (Sigma, Casp3f, Saint Louis, USA). Cells were cul-
tured in 6-well plates and treated with 6-OHDA
(100 μM) 6 h in the presence or absence of seaweeds ex-
tracts (1 mg/mL). After this period the culture medium
was removed, the cells were washed twice with Hank’s
buffer and collected by centrifugation (8000 rpm,
10 min, 4 °C). The pellets were resuspended in 100 μL
of lysis buffer and incubated 20 min on ice. In order to
separate the content of intracellular cytoplasmic organ-
elles and cells membranes, centrifugation took place at
14000 rpm during 20 min at 4 °C. Thereafter, 5 μL of
the obtained supernatant was place in to a 96-well plate
where it was added 200 μL of a substrate solution which
was prepared following the manufacturer’s instructions.
In this assay, the Caspase-3 activity is accessed by meas-
uring the fluorescence released by the fluorophore
rhodamine 110. When attached to the amino acid se-
quence, this fluorophore have a basal fluorescence, how-
ever, when detached from the amino acid sequence,
rhodamine 110 is highly fluorescent. Caspase-3 is spe-
cific for cleaving the rhodamine-aminoacid solution
(substrate) resulting in the fluorescent form of rhoda-
mine 110, the product. This reaction was followed at
wavelengths of 496 nm (excitation) and 520 nm (emis-
sion) along 60 min at room temperature. Caspase-3 ac-
tivity was calculated by the slope of the linear phase of
the fluorescence resulting from the rhodamine 110 accu-
mulation and expressed in arbitrary fluorescence units
per mg protein per minute (Δfluorescence (u.a)/mg of
protein/min).
Statistical analysis
One-way analysis of variance (ANOVA) with Dunnett’s
multiple comparison of group means were employed to
determine significant differences relatively to the control
treatment [38]. All other post-hoc analyses were
accessed through Tukey test. All data were checked for
normality and homoscedasticity. Comparisons concern-
ing variables, which did not meet variance or distribu-
tional assumptions, were carried out with Kruskal-Wallis
non-parametric tests [38]. Where applicable, results are
presented as mean ± standard error of the mean (SEM).
Differences were considered statistically significant at
level of 0.05 (that is, p < 0.05). All calculations were per-
formed using IBM SPSS Statistics 21 (IBM Corporation,
Armonk, NY, USA) and GraphPad v5.1 (Graphpad
Software, Inc. La Jolla, CA, USA). The determination
of IC50 was calculated by the analysis of non-linear
regression using GraphPad Prism software with the
eq. Y = 100/ (1 + 10 (X - LogIC50)) equation.
Results
Neurotoxic effects induced by 6-OHDA on SH-SY5Y cells
SH-SY5Y cells were exposed to different concentrations
of 6-OHDA (10–1000 μM) during 24 h. As can be ob-
served in the Fig. 1, 6-OHDA induced a concentration-
dependent effect on the viability of SH-SY5Y cells with
an IC50 of 116.7 μM (93.25–146.6). The highest neuro-
toxicity effect was obtained at 300 μM and 1000 μM
with a cell viability reduction of more than 80%. For the
concentrations (100–1000 μM) that exhibited neurotox-
icity on SH-SY5Y cells was defined the time-course ef-
fects after 6, 12, 24 and 48 h. All the tested
concentrations of 6-OHDA showed a time-dependent
effect (Fig. 1b).
Neuroprotective effect of seaweeds on SH-SY5Y cells
exposed to 6-OHDA
The exposition of SH-SY5Y cells to 6-OHDA (100 μM)
led to a reduction of about 35% (67.40 ± 3.56 of viable
cells) of cell’s viability. However, when 6-OHDA was in-
cubated with seaweeds (1 mg/mL), all extracts, with ex-
ception for the dichloromethane extract of S. muticum
exhibited capacity to totally blunt the toxicity induced
by 6-OHDA after 24 h of incubation (Fig. 2). On the
other hand, the dichloromethane extract of S. muticum
(84.73 ± 2.73% of viable cells) did not showed statistically
significant differences when compared to 6-OHDA situ-
ation (ANOVA, p > 0.05). These results were confirmed
both by the Calcein -AM assay that showed that all ex-
tracts protected cells from the toxic effects induced by
6-OHDA (Fig. 3a) and by the representative fluorescent
images of 6-OHDA treatment in the presence or in the
absence of the seaweeds extracts (Fig. 3b).
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Cellular mechanisms associated to the neurotoxicity
induced by 6-OHDA on SH-SY5Y cells in the presence or
absence of seaweeds extracts
Production of H2O2
In order to understand if the neurotoxicity induced by 6-
OHDA and the neuroprotection evidenced by seaweeds
extracts on cell viability of SH-SY5Y was associated with
oxidative stress, the H2O2 production was quantified.
The exposition of SH-SY5Y cells to 6-OHDA
(100 μM) led to an increase of more than twice the
levels of H2O2 comparing with vehicle (Fig. 4). More-
over, when the cells were incubated with 6-OHDA in
the presence of seaweeds extracts (1 mg/mL) the
levels of H2O2 decreased partially or totally when
compared with 6-OHDA. The highest decrease was
carried out by the dichloromethane extract of Codium
tomentosum (54.07 ± 6.66% of control) when com-
pared with 6-OHDA (214.26 ± 8.46% of control) and
vehicle (100.00 ± 9.48% of control). Within the ex-
tracts with neuroprotective potential, Ulva compressa
was the only extract that did not exhibited capacity
to decrease the H2O2 production induced by 6-
OHDA.
Fig. 1 Concentration dependent effect of 6-OHDA (10–1000 μM) on SH-SY5Y cells viability (% of control) after 24 h of incubation (a); IC50 obtained
from different concentrations of 6-OHDA (100-1000 μM) (b); Effect of 6 - OHDA (100–1000 μM) on SH-SY5Y cells viability (% of control) after different
times of incubation 6, 12, 24 and 48 h (c). Results were obtained by the MTT method. Values are mean ± SEM (n = 16). Symbols represent statistically
significant differences (p < 0.05, ANOVA, Tukey test) when compared to: *vehicle; #6 h; §12 h; + 24 h
Fig. 2 Neuroprotective effects of seaweeds extracts (1 mg/mL) on
SH-SY5Y cells exposed to 6-OHDA (100 μM). Determination of cell
viability by the MTT method (% control) after 24 h of incubation. Values
are mean ± SEM (n = 16). Symbols represent statistically significant
differences (p < 0.05, ANOVA, Dunett’s test) when compared to:
*vehicle. # to 6-OHDA
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Mitochondrial membrane potential (MMP)
The incubation of SH-SY5Y cells with 6-OHDA
(100 μM – 3 h) induced a strong depolarization of the
MMP when compared with vehicle (Fig. 5a). Moreover,
this effect was also time-dependent, since after 6 h of in-
cubation with 6-OHDA the depolarization increased
twice when compared with the 3 h exposure. During the
treatment with seaweeds (3 h) it was possible to observe
a noticeable preventive effect of S. muticum, C. tomento-
sum and U. compressa extracts in the depolarization in-
duced by 6-OHDA. On the other hand, the extracts of S.
polyschides and P. pavonica only prevented the effects
induced by 6-OHDA after 6 h of incubation (Fig. 5b).
Caspase-3 activity
In order to understand if the cell death promoted by 6-
OHDA is mediated by apoptosis, it was decided to study
the Caspase-3 activity, since it is an important biomarker
in this process. The results showed a noticeable increase
of Caspase-3 activity when SH-SY5Y cells were treated
with 100 μM of 6-OHDA (1536.72 ± 154.76% of control)
comparing with vehicle (100 ± 33.24% of control).
Furthermore, when cells were incubated with 6-OHDA
and seaweeds extracts (1 mg/mL) it was possible to
detect a reduction of Caspase-3 activity when com-
pared with 6-OHDA. The extracts from C. tomento-
sum, S. polyschides, P. pavonica and U. compressa
completely inhibited the stimulation of Caspase-3 by
6-OHDA. S. muticum also revealed this capacity but
the effects were not so marked (Fig. 6).
Discussion
PD is a neurodegenerative disease of the central nervous
system characterized by a progressive loss of dopamin-
ergic neurons that underlie the characteristic motor
symptoms. This disease still doesn’t have an affective
cure and therefore exists an increasing interest in the
development of more selective and effective therapeutic
agents in order to prevent or slow down the neurode-
generation progression [15, 18, 25, 26, 39]. Although the
causes PD pathogenesis remains incomplete, consider-
able evidences from human and animal studies have
suggested that mechanisms such as oxidative stress,
mitochondrial and lysosomal dysfunctions, neuroinflam-
matory processes, and the formation of pathologic inclu-
sions contributes to neuronal death in PD [4, 5]. In line
with this, the present study was designed to evaluate the
Fig. 3 Neuroprotective effects of seaweeds extracts (1 mg/mL) on SH-SY5Y cells exposed to 6-OHDA (100 μM) revealed by Calcein-AM method
a) Read of fluorescence (% control) after 24 h of incubation. Values are mean ± SEM (n = 8). Symbols represent statistically significant differences
(p < 0.05, ANOVA, Dunett’s test) when compared to: * vehicle. # to 6-OHDA. b Observation by fluorescence microscopy of the effects induced by
6-OHDA and seaweeds extracts. The images are representative of each treatment done and correspond to the center-point of one well. Methanolic
extract: Sargassum muticum, Padina pavonica and Saccorhiza polyschides; Dichloromethane extract: Codium tomentosum and Ulva compressa
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protective effects of seaweeds on SH-SY5Y cells exposed
to the toxicity of 6-OHDA.
The neurotoxicity induced by 6-OHDA on SH-SY5Y
cells has been previously reported by different authors,
consequently, this model has been widely used to mimic
experimental models of PD [5, 6, 11, 40]. According to
previous studies, once inside the neurons, 6-OHDA
accumulates and undergoes a non-enzymatic auto-
oxidation, promoting the reactive oxygen species forma-
tion (e.g. superoxide radical, hydrogen peroxide, quinones
and hydroxyl radicals) and inhibit the mitochondrial com-
plexes I and IV, causing adenosine triphosphate (ATP) de-
pletion. All these supports the hypothesis that oxidative
stress and mitochondrial dysfunction may be responsible
for the cell death [5, 41, 42]. Moreover, these two events
are described as being entirely related, since the occur-
rence of mitochondrial dysfunction can lead to ATP de-
pletion, inducing irreversible effects on the cellular
processes, leading to the formation of free radicals. Conse-
quently, the loss of mitochondrial transmembrane poten-
tial can result in the rupture of the outer mitochondrial
membrane and in the release of pro-apoptotic proteins
from the nucleus leading to cell death through activation
of the intrinsic apoptosis pathway [43–45]. Our results are
entirely according with these facts, since the observed re-
duction on SH-SY5Y cells viability was accompanied by an
increase of H2O2 production, depolarization of mitochon-
drial membrane potential and an increase of Caspase-3
activity, suggesting that cell death induced by the 6-
OHDA treatment was mediated by these mechanisms.
Moreover, our results are supported by Esmaeili-Mahani
and co-workers [11] that observed a significant increase of
intracellular ROS, activated Caspase 3, Bax/Bcl-2 ratio,
cytochrome c as well as DNA fragmentation in 6-OHDA-
treated cells. For other side, when SH-SY5Y cells were
treatment with 6-OHDA in the presence of seaweeds ex-
tracts was possible to see a marked increase of cell’s viabil-
ity. The data obtained suggests that the protective effects
induced by seaweeds extracts result in a reduction of oxi-
dative stress condition (H2O2 production pathway) and an
anti-apoptotic effect (mitochondrial protection and de-
crease of Caspase-3 activity). Several experiments revealed
that therapies including the intake of antioxidants display
a protective effect on the degeneration of dopaminergic
neurons suggesting that pharmacological targeting of the
Fig. 5 6-OHDA (100 μM) effects in the presence or absence of
seaweeds extracts (1 mg/mL) in mitochondrial membrane potential
of SH-SY5Y cells after 3 h (a) and 6 h (b) of incubation. The results
were obtained by the ratio between the monomers/aggregates of
JC-1. The values in each column represent the mean ± standard error
of the mean (SEM) of 3 or 4 independent experiments. Symbols
represent statistically significant differences (p < 0.05, ANOVA,
Dunett’s test) when compared to: *vehicle. # to 6-OHDA
Fig. 4 Levels of hydrogen peroxide (H2O2) produced by SH-SY5Y cells
after 12 h of incubation with 6-OHDA (100 μM) in presence or absence
of seaweeds extracts (1 mg/mL). H2O2 was quantified fluorimetrically
using the “™ Amplex red hydrogen peroxide assay” kit. Symbols
represent statistically significant differences (p < 0.05, ANOVA,
Dunett’s test) when compared to: *vehicle. # to 6-OHDA
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antioxidant machinery may have therapeutic value
[6, 16–19, 46]. According with this, the neuroprotec-
tive effects of seaweeds can be mediated by the anti-
oxidants molecules present in their extracts, since
these were selected by having a high antioxidant capacity.
Among marine organisms, seaweeds are an interesting
source of new compounds with antioxidant activity and
neuroprotective potential. They are subjected to periods
of immersion and emersion being exposed to rapid varia-
tions of light, UV rays and different oxygen (O2) and car-
bon dioxide (CO2) concentrations, factors that are related
with oxidizing effects. This situation stimulates the pro-
duction of antioxidant defenses, such as the production of
phenolic compounds [47, 48]. The protective effects ex-
hibited by seaweeds belonging to the brown algae group
(S. muticum, S. polyschides and P. pavonica) can be associ-
ated with the presence of phlorotannins (molecules pro-
duced exclusively by brown algae). Phlorotannins, are
phenolic compounds with a strong antioxidant capability
[49, 50] suggesting that these may be responsible by the
observed reduction of H2O2 levels. In fact, seaweeds have
revealed to produce a high diversity of compounds with
antioxidant activity. Codium tomentosum, a green seaweed
also revealed an oxidative-stress protective effect. Celikler
and co-workers [51] demonstrated that C. tomentosum ex-
tracts have strong anti-oxidative activity which can explain
the highest reduction of the H2O2 production observed in
presence of this extract.
On the other hand, several studies reported that the
neuroprotection effect of different compounds is nor-
mally mediated by the prevention of mitochondrial
depolarization, the reduction of ROS levels and the in-
hibition of apoptotic process leading to an increase of
cell’s viability [11, 52, 53]. In our study was also possible
to observe these effects, since the increase of cell’s viabil-
ity by seaweeds extracts seems to be mediated by the re-
duction of H2O2 levels, the protection of mitochondrial
membrane potential and the inhibition of Caspase-3 ac-
tivity. According to our results, several other compounds
of natural origin such as, astaxanthin (obtained from
Haematococcus pluvialis) and 11-dehydrosinulariolide
(obtained from the coral Sinularia flexibilis) have exhib-
ited anti-apoptotic effects, notably by decreasing the
Caspase-3 expression and cytochrome c in SH-SY5Y
cells when treated 6-OHDA. Similarly, the neuropeptide
orexin-A, exhibit anti-apoptotic effects by the same
mechanisms [6, 11, 31]. In line with our findings,
Jhamandas and co-workers [54] showed neuroprotective
activity of a fucoidan sulfated polysaccharide, isolated
from the brown seaweed Fucus vesiculosus, through the
ability to protect neuronal death in rats treated with
Aβ1–42 the by inhibition of Caspase-3 in an Alzheimer’s
disease model. Although not directly related to the dis-
ease addressed in this work, the effects induced by fucoi-
dan demonstrate the potential of seaweeds as source of
new neuroprotective molecules.
Conclusions
In conclusion, the seaweeds extracts with high antioxi-
dant capacity analyzed in this study showed to be a
promising source of new compounds with neuroprotec-
tive potential revealing capacity to increase the SH-SY5Y
cell’s viability by the reduction of H2O2 levels, the pro-
tection of mitochondrial membrane potential and the in-
hibition of Caspase-3 activity, reducing the neurotoxic
effects induced by 6-OHDA.
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